CD209 and melanoma: We have identified and characterized four conventional DC subsets in melanoma SLN, two of which were positively identified as skin-derived CD1a+LC and DDC, and the remaining two (CD1a−CD14− and CD1a−CD14+) as LN-resident subsets with varying levels of BDCA3 and DC-SIGN expression (52).